default author photo

Qin Wen

Government of the People's Republic of China - Department of Hematology

Chongqing

China

SCHOLARLY PAPERS

2

DOWNLOADS

238

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Effect of rhG-CSF Combined with Decitabine Prophylaxis on Relapse in High-Risk Acute Myeloid Leukemia Patients after Hematopoietic Stem Cell Transplantation: An Open-Label, Multicenter, Randomized, Controlled, Phase 2 Trial

Number of pages: 84 Posted: 26 Nov 2019
Lei Gao, Yanqi Zhang, Sanbin Wang, Peiyan Kong, Yi Su, Jiong Hu, Ming Jiang, Hai Bai, Tao Lang, Jishi Wang, Li Liu, Tonghua Yang, Xiaobin Huang, Fang Liu, Shifeng Lou, Yao Liu, Cheng Zhang, Hong Liu, Li Gao, Jia Liu, Lidan Zhu, Qin Wen, Ting Chen, Ping Wang, Jun Rao, Min Mao, Cunbang Wang, Xianlin Duan, Le Luo, Xiangui Peng, Kaniel Cassady, Jiangfan Zhong and Xi Zhang
Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - College of Preventive Medicine, Government of the People's Republic of China - General Hospital of Kunming Military Region, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - General Hospital of Kunming Military Region, Shanghai Jiao Tong University (SJTU) - Shanghai Institute of Hematology, Xinjiang Medical University, Government of the People's Republic of China - General Hospital of Lanzhou Military Region, Xinjiang Provincial People's Hospital, Guizhou Medical University (Guiyang Medical University) - Department of Hematology, Government of the People's Republic of China - Tangdu Hospital, Government of the People's Republic of China - Yunan Provincial People’s Hospital, Government of the People's Republic of China - Sichuan Provincial People's Hospital, Government of the People's Republic of China - General Hospital of Chengdu Military Region of the PLA, Chongqing Medical University - Second Affiliated Hospital, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Department of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Xinjiang Provincial People's Hospital, Government of the People's Republic of China - General Hospital of Lanzhou Military Region, Xinjiang Medical University, Government of the People's Republic of China - General Hospital of Kunming Military Region, Government of the People's Republic of China - Department of Hematology, City of Hope - Beckman Research Institute, Government of the People's Republic of China - Department of Hematology and Government of the People's Republic of China - Medical Center of Hematology
Downloads 119 (600,462)

Abstract:

Loading...

acute myeloid leukemia; high risk; allogeneic hematopoietic stem cell transplantation; decitabine; granulocyte colony-stimulating factor; relapse

2.

Tandem Autologous Hematopoietic Stem Cell Transplantation for Treatment of Adult T-Cell Lymphoblastic Lymphoma: A Multiple Center Prospective Study in Southwestern China

Number of pages: 31 Posted: 16 Jan 2019
Yao Liu, Jun Rao, Jiali Li, Qin Wen, Sanbin Wang, Shifeng Lou, Tonghua Yang, Bin Li, Lei Gao, Cheng Zhang, Peiyan Kong, Li Gao, Maihong Wang, Lidan Zhu, Xixi Xiang, Sha Zhou, Xue Liu, Xiangui Peng, Jiangfan Zhong and Xi Zhang
Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Department of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Department of Hematology, Government of the People's Republic of China - General Hospital of Kunming Military Region, Chongqing Medical University - Second Affiliated Hospital, Government of the People's Republic of China - Yunan Provincial People’s Hospital, Second Yunnan Provincial People's Hospital, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Department of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Department of Hematology, Government of the People's Republic of China - Department of Hematology, Government of the People's Republic of China - Department of Hematology, Government of the People's Republic of China - Department of Hematology, Government of the People's Republic of China - Department of Hematology and Government of the People's Republic of China - Medical Center of Hematology
Downloads 119 (600,462)

Abstract:

Loading...

T-cell lymphoblastic lymphoma, autologous hematopoietic stem cell transplantation, progression-free survival, progression/relapse rate, overall survival